| VCNX Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the VCNX shares outstanding history going back to 8/14/2018:
Also see: VCNX Market Cap History VCNX YTD Return |
As of 4/11/2025 Vaccinex has 2.68 million VCNX shares outstanding. Investors often track the VCNX shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows VCNX share count trends over time, with 27 historical shares outstanding datapoints presented, dating back to 8/14/2018.

| VCNX Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the VCNX shares outstanding history going back to 8/14/2018:
Also see: VCNX Market Cap History VCNX YTD Return |
| VCNX Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
VCNX Historical Shares Outstanding: +79.33% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| VCNX Stock Price Chart |
| About Vaccinex Inc |
| Vaccinex, Inc. is a clinical-stage biotechnology company. Co. is engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including neurodegenerative diseases, cancer, and autoimmune disorders. Its lead product candidate, pepinemab, is in clinical development for the treatment of Alzheimer's disease, head and neck, pancreatic and breast cancer. Its lead platform technologies include SEMA4D antibody platform and ActivMAb antibody discovery platform. We show 27 historical shares outstanding datapoints in our coverage of VCNX's shares outstanding history. Understanding the changing numbers of VCNX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like VCNX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching VCNX by allowing them to research VCNX shares outstanding history as well as any other stock in our coverage universe. |
| VCNX Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| VCNX Share Performance |
| Shares Outstanding Peers |
| Vaccinex (VCNX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
VCYT Shares Outstanding History VERA Shares Outstanding History VERO Shares Outstanding History VERU Shares Outstanding History VERV Shares Outstanding History VICL Shares Outstanding History VIE Shares Outstanding History VIGL Shares Outstanding History VINC Shares Outstanding History VIR Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.